Search for: "SCHERING-PLOUGH" Results 121 - 140 of 404
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Mar 2011, 4:29 pm by Eric Schweibenz
., Inc. of Whitehouse Station, New Jersey Schering Plough Corporation of Kenilworth, New Jersey Organon USA, Inc. of Durham, North Carolina N.V. [read post]
25 Mar 2011, 1:21 pm by Barry Barnett
Blawgletter wrote a paper class cert in antitrust cases for a Practising Law Institute program that went webinar last month. [read post]
16 Mar 2011, 8:35 am by Emory Law Journal
Spriggs II, The Most Important (and Best) Supreme Court Opinions and Justices Comments Daniel Soleimani, The Difficulties with the Subpart F System of International Taxation: How the Schering-Plough Decision Indicates that the Status Quo Is Unclear and Unwise Amy E. [read post]
28 Feb 2011, 6:58 pm by Eric Schweibenz
Organon, which is a wholly owned subsidiary of Merck & Co., Inc. and is related to Organon USA, Inc. and Schering Plough Corporation. [read post]
11 Feb 2011, 7:51 am by Peter Rost
BIOGRAPHY AND CV CONTACT INFORMATION CLIENT LISTEXPERT WITNESS SERVICESMEDIACONGRESS LETTER ON BEHALF OF DR. [read post]
10 Jan 2011, 11:00 am
 Schering Plough responded with a motion to dismiss on the basis that Shareholders failed to plead futility of demand as required by the Federal Rules of Civil Procedure. [read post]
16 Dec 2010, 4:04 pm by Phillips & Cohen
.- Four large pharmaceutical companies (GlaxoSmithKline, Pfizer, Eli Lilly, and Schering-Plough) accounted for more than half (53 percent or $10.5 billion) of all financial penalties imposed over the past two decades. - The pharmaceutical industry now tops not only the defense industry, but all other industries in the total amount of fraud payments for actions against the federal government under the False Claims Act. - Illegal off-label promotion of pharmaceuticals accounts for… [read post]
8 Dec 2010, 10:42 am by FDABlog HPM
Geneva Pharms., Inc., 344 F.3d 1294, 1303 (11th Cir. 2003) and in Schering-Plough Corp. v. [read post]
1 Dec 2010, 12:15 am by Kelly
TM 216996 – Schering Plough (The IP Factor) Concerta (Methylphenidate) – US: Impax Laboratories confirms patent suit relating to generic Concerta 54 mg tablets (SmartBrief) Hycamtin (Topotecan) – US: APP Pharmaceuticals announces approval and launch of Topotecan for injection (SmartBrief) Lovaza (Omega-3) – US: Pronova Biopharma receives Lovaza paragraph IV notice letter from Apotex Inc (GenericsWeb) Naropin (Ropivacaine) – UK: Assigned or not? [read post]
19 Oct 2010, 7:31 am by David Feldman
Much larger Merck combined with Schering-Plough in a reverse merger last year. [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical, Inc; Schering-Plough Healthcare Products, Inc. et al. v. [read post]
26 Aug 2010, 10:36 am by Rebecca Tushnet
Schering-Plough Healthcare Prods., Inc. v. [read post]
20 Aug 2010, 12:56 pm by Stephen Albainy-Jenei
Significant Case Studies Give You The Chance To Learn About New Partnerships and New Agreements In The Industry * BMS and Allergan * Merck and Schering-Plough * Sanofi-Aventis and Intelliject * J&J and Takeda * Eli Lilly and Kowa Pharmaceuticals * Eli Lilly and Incyte Corporation The Perfect Pitch: Biotech Investment Challenge In this groundbreaking session, Biotech companies will have the chance to present your new research and new therapies (either in early stages or mid-late… [read post]